Antibody-mediated rejection in a lung transplant recipient after acute stroke.
Antibody-mediated rejection (AMR) is becoming a more recognized problem in lung transplantation. We present a case of late onset AMR in a lung transplant recipient after an acute embolic stroke requiring thrombolytic therapy, who previously had a completely unremarkable course for over 3 years.
Department of Pediatrics, The Ohio State University College of Medicine, United States. hayes.705@osu.edu
Don
D
Hayes
Nicholas
N
DiPaola
Peter B
PB
Baker
Stephen
S
Kirkby
Alistair B
AB
Phillips
Kathleen K
KK
Nicol
D015933:Complement C3d / Q000378:metabolism; D015935:Complement C4b / Q000378:metabolism; D003550:Cystic Fibrosis / Q000601:surgery; D017809:Fatal Outcome; D005260:Female; D006084:Graft Rejection / Q000209:etiology* / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007518:Isoantibodies / Q000378:metabolism; D008168:Lung / Q000276:immunology / Q000473:pathology; D016040:Lung Transplantation / Q000009:adverse effects* / Q000276:immunology* / Q000473:pathology; D010446:Peptide Fragments / Q000378:metabolism; D020521:Stroke / Q000150:complications* / Q000276:immunology*; D013997:Time Factors; D014019:Tissue Donors; D055815:Young Adult
D007518:Isoantibodies; D010446:Peptide Fragments; D015933:Complement C3d; D015935:Complement C4b; C032261:complement C4d